A Framework for Fitness-for-Purpose and Reuse in Computational Phenotyping
November 17, 2025
Background
Trichomoniasis is a sexually transmitted infection (STI). It is caused by a protozoan parasite Trichomonas Vaginalis. It affects urogenital tract which includes female vagina and male urethra. Trichomoniasis can cause symptoms like itching, vaginal discharge, and pain during urination in women. In men, it causes urethral discharge and discomfort. It is a very prevalent STI, with millions of cases globally each year. Trichomoniasis can lead to severe and serious health issues like increased risk of transmitting or acquiring other STIs and difficulty during pregnancy if it is not treated. Proper diagnosis and immediate treatment are important to manage and control the spread of the infection. Safe sexual activity and regular screening are important to prevent this infection.Â
Epidemiology
Trichomoniasis is most common disease. About 143 million people are infected globally. It can affect all ages of individuals. The high prevalence rate is seen in sexually active people, specifically whose age is between 16 years to 35 years. Women are more affected than men due to the parasite mainly infected the urogenital tract in women. This can lead to symptoms like itching and vaginal discharge. The symptoms are mild in men. Â
The prevalence rate is differed by areas. It is common in areas with low socioeconomic status, and limited healthcare service. Trichomoniasis can occur with other STIs like gonorrhea and chlamydia which can elevate the risk of transmission and complications. Trichomoniasis is a significant risk during pregnancy. It is linked with low birth weight and premature birth. It is important to diagnose and treat pregnant women for this infection.Â
Anatomy
Pathophysiology
Trichomoniasis is mainly transmitted by sexual contact. When an infected patient has sexual contact with the uninfected person, this parasite transmitted. It has a unique structure of undulating membrane and flagella which can make it move to the mucosal cells in the urogenital tract. Â
Trichomoniasis lead to inflammation in the urogenital mucosa because of the presence of parasite and immune response of host. This can lead to different symptoms like itching, vaginal discharge, and discomfort. It causes the vaginitis in women. It can lead to symptoms like a greenish yellow, a frothy vaginal discharge with a foul odor. It causes vulvovaginal burning. Itching and pain during intercourse or urination. It causes urethritis in men. It can lead to symptoms like itching, urethral discharge, and minor discomfort. Â
Trichomoniasis can lead to a chronic infection in some cases with recurrent symptoms and high risk of complications. It is necessary to know that not every infected individuals have symptoms of this disease. Â
Etiology
Trichomoniasis mainly occurred by the protozoan Trichomonas vaginalis. It contains single celled organism which is motile with unique appearance. Trichomoniasis is transmitted by sexual contact, which includes vaginal, anal, or oral sex with infected individual. The primary source of Trichomonas vaginalis is human. It infects the urogenital tract, which includes the female vagina and male urethra. The risk of trichomoniasis is unprotected sexual intercourse with infected person, multiple sexual partners, and high risk of sexual behaviors.  Â
Genetics
Prognostic Factors
Early detection of the disease and treatment are the main prognostic factors. Delay in diagnosis and treatment may cause persistent and worse infection, which can lead to complications. The immune system of host plays role in the progression of infection. Individual who has weak immune system along with HIV and AIDS or other immunosuppressive disease may have a high risk of severe and recurrent infection.Â
The presence of other STIs like HIV may lead to complications to the prognosis. Some strains of Trichomonas vaginalis are resistant to common antibiotics, which can affect the treatment. Drug resistance medications can lead to failure of treatment and infection to reoccurrence. Sexual activity with an infected or untreated person can lead to reinfection of this disease after the successful treatment. Â
Clinical History
Trichomoniasis may affect any age of individuals who are sexually active. Â
Physical Examination
Age group
Associated comorbidity
Trichomoniasis is not linked with specific comorbidities. STIs like HIV and other immunosuppressive disease may be concern. It can affect the treatment and course of infection.Â
Associated activity
Acuity of presentation
Acute Presentation: Many patients who have trichomoniasis are asymptomatic. Other may have symptoms like vaginal itching or discomfort, greenish yellow, frothy and foul smell of vaginal discharge, genital swelling and redness, and lower discomfort in abdomen. Â
Chronic Presentation: Some individuals have prolonged and persist symptoms which are known. Chronic trichomoniasis may elevate the risk of complication and linked with other health condition. Â
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Trichomoniasis is diagnosed by laboratory test. The samples are collected from vagina or urethra or urine. The diagnostic tests are nucleic acid amplification test (NAAT), wet mount microscopy, or culture. Â
The primary treatment of trichomoniasis is antimicrobial medications. This includes metronidazole (Flagyl) which is most effective against the parasite. The recommended single dose is 2 gm orally. A 7-day course of metronidazole is 500 mg daily 2 times can also be recommended. Tinidazole can also be administered as a single dose of 2 gm or 7-day course of 500 mg 2 times a day. Â
Retesting of trichomoniasis is suggested within 3 months of completed treatment specifically for women. This can help to make sure that the infection is completely cleared. Â
Individuals should take follow up from healthcare provider if symptoms persist or reoccur after treatment. It is good to not have any sexual activity till both infected person completed the treatment and get confirmation of cure. Correct use of condoms can lower the risk of transmission or reinfection of trichomoniasis or other STIs.Â
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
non-pharmacological-treatment-to-treat-trichomoniasis
Lifestyle modifications:Â
Use of Nitroimidazoles to treat trichomoniasis
The primary treatment of trichomoniasis includes the use of nitroimidazoles. It is a class of antimicrobial agents which are effective against this parasite. It includes medications like Tinidazole (Tindamax), Metronidazole (Flagyl), Secnidazole (Solosec), and Clotrimazole.Â
surgical-procedures-involved-to-treat-trichomoniasis
Surgical procedures are not suggested to treat this STI. This can be considered in certain cases with other complication of infections or conditions.Â
management-to-treat-trichomoniasis
Acute Phase: The main focus is to diagnose the infection and give immediate treatment to eliminate the parasite during the acute phase.Â
Trichomoniasis may be asymptomatic and make the diagnosis more challenging. Test the samples like swabs and urine from urogenital or genital area and check for the presence of Trichomonas vaginalis. Laboratory tests like NAATs are used to diagnose. Â
Healthcare providers give antimicrobial medications like metronidazole and tinidazole to treat trichomoniasis. Individuals who are sexually contacted are diagnosed, tested, and treated if the infection is present. It is advisable to not have any sexual activity till the curation of disease to prevent the spread of infection.Â
Chronic Phase: It includes to manage and prevent trichomoniasis.Â
After the antibiotic treatment, patient must go for follow up test to conform the clearance of infection specifically during pregnancy. Take prevention which include safe sex and regular screening of STIs. Education of trichomoniasis is necessary to prevent it. Pregnant women must be closely monitored to premature birth and low birth weight need immediate treatment and follow up.Â
Medication
1
packet
Orally 
daily
250 mg of the drug to be taken orally every 8 hours for 7 days
if taking a single dose, 2 gm oral should be the dose per day
Take a dose of 250 mg orally two times a day up to 4 days
Age: >12 years:
1
packet
Orally 
daily
For body weight <45 kg- 15 mg/kg orally or intravenously every 8 hours for 7 days
Do not exceed the dose of more than 2 gm/day
Future Trends
References
https://www.ncbi.nlm.nih.gov/books/NBK534826/
Trichomoniasis is a sexually transmitted infection (STI). It is caused by a protozoan parasite Trichomonas Vaginalis. It affects urogenital tract which includes female vagina and male urethra. Trichomoniasis can cause symptoms like itching, vaginal discharge, and pain during urination in women. In men, it causes urethral discharge and discomfort. It is a very prevalent STI, with millions of cases globally each year. Trichomoniasis can lead to severe and serious health issues like increased risk of transmitting or acquiring other STIs and difficulty during pregnancy if it is not treated. Proper diagnosis and immediate treatment are important to manage and control the spread of the infection. Safe sexual activity and regular screening are important to prevent this infection.Â
Trichomoniasis is most common disease. About 143 million people are infected globally. It can affect all ages of individuals. The high prevalence rate is seen in sexually active people, specifically whose age is between 16 years to 35 years. Women are more affected than men due to the parasite mainly infected the urogenital tract in women. This can lead to symptoms like itching and vaginal discharge. The symptoms are mild in men. Â
The prevalence rate is differed by areas. It is common in areas with low socioeconomic status, and limited healthcare service. Trichomoniasis can occur with other STIs like gonorrhea and chlamydia which can elevate the risk of transmission and complications. Trichomoniasis is a significant risk during pregnancy. It is linked with low birth weight and premature birth. It is important to diagnose and treat pregnant women for this infection.Â
Trichomoniasis is mainly transmitted by sexual contact. When an infected patient has sexual contact with the uninfected person, this parasite transmitted. It has a unique structure of undulating membrane and flagella which can make it move to the mucosal cells in the urogenital tract. Â
Trichomoniasis lead to inflammation in the urogenital mucosa because of the presence of parasite and immune response of host. This can lead to different symptoms like itching, vaginal discharge, and discomfort. It causes the vaginitis in women. It can lead to symptoms like a greenish yellow, a frothy vaginal discharge with a foul odor. It causes vulvovaginal burning. Itching and pain during intercourse or urination. It causes urethritis in men. It can lead to symptoms like itching, urethral discharge, and minor discomfort. Â
Trichomoniasis can lead to a chronic infection in some cases with recurrent symptoms and high risk of complications. It is necessary to know that not every infected individuals have symptoms of this disease. Â
Trichomoniasis mainly occurred by the protozoan Trichomonas vaginalis. It contains single celled organism which is motile with unique appearance. Trichomoniasis is transmitted by sexual contact, which includes vaginal, anal, or oral sex with infected individual. The primary source of Trichomonas vaginalis is human. It infects the urogenital tract, which includes the female vagina and male urethra. The risk of trichomoniasis is unprotected sexual intercourse with infected person, multiple sexual partners, and high risk of sexual behaviors.  Â
Early detection of the disease and treatment are the main prognostic factors. Delay in diagnosis and treatment may cause persistent and worse infection, which can lead to complications. The immune system of host plays role in the progression of infection. Individual who has weak immune system along with HIV and AIDS or other immunosuppressive disease may have a high risk of severe and recurrent infection.Â
The presence of other STIs like HIV may lead to complications to the prognosis. Some strains of Trichomonas vaginalis are resistant to common antibiotics, which can affect the treatment. Drug resistance medications can lead to failure of treatment and infection to reoccurrence. Sexual activity with an infected or untreated person can lead to reinfection of this disease after the successful treatment. Â
Trichomoniasis may affect any age of individuals who are sexually active. Â
Trichomoniasis is not linked with specific comorbidities. STIs like HIV and other immunosuppressive disease may be concern. It can affect the treatment and course of infection.Â
Acute Presentation: Many patients who have trichomoniasis are asymptomatic. Other may have symptoms like vaginal itching or discomfort, greenish yellow, frothy and foul smell of vaginal discharge, genital swelling and redness, and lower discomfort in abdomen. Â
Chronic Presentation: Some individuals have prolonged and persist symptoms which are known. Chronic trichomoniasis may elevate the risk of complication and linked with other health condition. Â
Trichomoniasis is diagnosed by laboratory test. The samples are collected from vagina or urethra or urine. The diagnostic tests are nucleic acid amplification test (NAAT), wet mount microscopy, or culture. Â
The primary treatment of trichomoniasis is antimicrobial medications. This includes metronidazole (Flagyl) which is most effective against the parasite. The recommended single dose is 2 gm orally. A 7-day course of metronidazole is 500 mg daily 2 times can also be recommended. Tinidazole can also be administered as a single dose of 2 gm or 7-day course of 500 mg 2 times a day. Â
Retesting of trichomoniasis is suggested within 3 months of completed treatment specifically for women. This can help to make sure that the infection is completely cleared. Â
Individuals should take follow up from healthcare provider if symptoms persist or reoccur after treatment. It is good to not have any sexual activity till both infected person completed the treatment and get confirmation of cure. Correct use of condoms can lower the risk of transmission or reinfection of trichomoniasis or other STIs.Â
Dermatology, General
Infectious Disease
Urology
Lifestyle modifications:Â
Dermatology, General
Infectious Disease
Urology
The primary treatment of trichomoniasis includes the use of nitroimidazoles. It is a class of antimicrobial agents which are effective against this parasite. It includes medications like Tinidazole (Tindamax), Metronidazole (Flagyl), Secnidazole (Solosec), and Clotrimazole.Â
Dermatology, General
Infectious Disease
Urology
Surgical procedures are not suggested to treat this STI. This can be considered in certain cases with other complication of infections or conditions.Â
Dermatology, General
Infectious Disease
Urology
Acute Phase: The main focus is to diagnose the infection and give immediate treatment to eliminate the parasite during the acute phase.Â
Trichomoniasis may be asymptomatic and make the diagnosis more challenging. Test the samples like swabs and urine from urogenital or genital area and check for the presence of Trichomonas vaginalis. Laboratory tests like NAATs are used to diagnose. Â
Healthcare providers give antimicrobial medications like metronidazole and tinidazole to treat trichomoniasis. Individuals who are sexually contacted are diagnosed, tested, and treated if the infection is present. It is advisable to not have any sexual activity till the curation of disease to prevent the spread of infection.Â
Chronic Phase: It includes to manage and prevent trichomoniasis.Â
After the antibiotic treatment, patient must go for follow up test to conform the clearance of infection specifically during pregnancy. Take prevention which include safe sex and regular screening of STIs. Education of trichomoniasis is necessary to prevent it. Pregnant women must be closely monitored to premature birth and low birth weight need immediate treatment and follow up.Â
https://www.ncbi.nlm.nih.gov/books/NBK534826/
Trichomoniasis is a sexually transmitted infection (STI). It is caused by a protozoan parasite Trichomonas Vaginalis. It affects urogenital tract which includes female vagina and male urethra. Trichomoniasis can cause symptoms like itching, vaginal discharge, and pain during urination in women. In men, it causes urethral discharge and discomfort. It is a very prevalent STI, with millions of cases globally each year. Trichomoniasis can lead to severe and serious health issues like increased risk of transmitting or acquiring other STIs and difficulty during pregnancy if it is not treated. Proper diagnosis and immediate treatment are important to manage and control the spread of the infection. Safe sexual activity and regular screening are important to prevent this infection.Â
Trichomoniasis is most common disease. About 143 million people are infected globally. It can affect all ages of individuals. The high prevalence rate is seen in sexually active people, specifically whose age is between 16 years to 35 years. Women are more affected than men due to the parasite mainly infected the urogenital tract in women. This can lead to symptoms like itching and vaginal discharge. The symptoms are mild in men. Â
The prevalence rate is differed by areas. It is common in areas with low socioeconomic status, and limited healthcare service. Trichomoniasis can occur with other STIs like gonorrhea and chlamydia which can elevate the risk of transmission and complications. Trichomoniasis is a significant risk during pregnancy. It is linked with low birth weight and premature birth. It is important to diagnose and treat pregnant women for this infection.Â
Trichomoniasis is mainly transmitted by sexual contact. When an infected patient has sexual contact with the uninfected person, this parasite transmitted. It has a unique structure of undulating membrane and flagella which can make it move to the mucosal cells in the urogenital tract. Â
Trichomoniasis lead to inflammation in the urogenital mucosa because of the presence of parasite and immune response of host. This can lead to different symptoms like itching, vaginal discharge, and discomfort. It causes the vaginitis in women. It can lead to symptoms like a greenish yellow, a frothy vaginal discharge with a foul odor. It causes vulvovaginal burning. Itching and pain during intercourse or urination. It causes urethritis in men. It can lead to symptoms like itching, urethral discharge, and minor discomfort. Â
Trichomoniasis can lead to a chronic infection in some cases with recurrent symptoms and high risk of complications. It is necessary to know that not every infected individuals have symptoms of this disease. Â
Trichomoniasis mainly occurred by the protozoan Trichomonas vaginalis. It contains single celled organism which is motile with unique appearance. Trichomoniasis is transmitted by sexual contact, which includes vaginal, anal, or oral sex with infected individual. The primary source of Trichomonas vaginalis is human. It infects the urogenital tract, which includes the female vagina and male urethra. The risk of trichomoniasis is unprotected sexual intercourse with infected person, multiple sexual partners, and high risk of sexual behaviors.  Â
Early detection of the disease and treatment are the main prognostic factors. Delay in diagnosis and treatment may cause persistent and worse infection, which can lead to complications. The immune system of host plays role in the progression of infection. Individual who has weak immune system along with HIV and AIDS or other immunosuppressive disease may have a high risk of severe and recurrent infection.Â
The presence of other STIs like HIV may lead to complications to the prognosis. Some strains of Trichomonas vaginalis are resistant to common antibiotics, which can affect the treatment. Drug resistance medications can lead to failure of treatment and infection to reoccurrence. Sexual activity with an infected or untreated person can lead to reinfection of this disease after the successful treatment. Â
Trichomoniasis may affect any age of individuals who are sexually active. Â
Trichomoniasis is not linked with specific comorbidities. STIs like HIV and other immunosuppressive disease may be concern. It can affect the treatment and course of infection.Â
Acute Presentation: Many patients who have trichomoniasis are asymptomatic. Other may have symptoms like vaginal itching or discomfort, greenish yellow, frothy and foul smell of vaginal discharge, genital swelling and redness, and lower discomfort in abdomen. Â
Chronic Presentation: Some individuals have prolonged and persist symptoms which are known. Chronic trichomoniasis may elevate the risk of complication and linked with other health condition. Â
Trichomoniasis is diagnosed by laboratory test. The samples are collected from vagina or urethra or urine. The diagnostic tests are nucleic acid amplification test (NAAT), wet mount microscopy, or culture. Â
The primary treatment of trichomoniasis is antimicrobial medications. This includes metronidazole (Flagyl) which is most effective against the parasite. The recommended single dose is 2 gm orally. A 7-day course of metronidazole is 500 mg daily 2 times can also be recommended. Tinidazole can also be administered as a single dose of 2 gm or 7-day course of 500 mg 2 times a day. Â
Retesting of trichomoniasis is suggested within 3 months of completed treatment specifically for women. This can help to make sure that the infection is completely cleared. Â
Individuals should take follow up from healthcare provider if symptoms persist or reoccur after treatment. It is good to not have any sexual activity till both infected person completed the treatment and get confirmation of cure. Correct use of condoms can lower the risk of transmission or reinfection of trichomoniasis or other STIs.Â
Dermatology, General
Infectious Disease
Urology
Lifestyle modifications:Â
Dermatology, General
Infectious Disease
Urology
The primary treatment of trichomoniasis includes the use of nitroimidazoles. It is a class of antimicrobial agents which are effective against this parasite. It includes medications like Tinidazole (Tindamax), Metronidazole (Flagyl), Secnidazole (Solosec), and Clotrimazole.Â
Dermatology, General
Infectious Disease
Urology
Surgical procedures are not suggested to treat this STI. This can be considered in certain cases with other complication of infections or conditions.Â
Dermatology, General
Infectious Disease
Urology
Acute Phase: The main focus is to diagnose the infection and give immediate treatment to eliminate the parasite during the acute phase.Â
Trichomoniasis may be asymptomatic and make the diagnosis more challenging. Test the samples like swabs and urine from urogenital or genital area and check for the presence of Trichomonas vaginalis. Laboratory tests like NAATs are used to diagnose. Â
Healthcare providers give antimicrobial medications like metronidazole and tinidazole to treat trichomoniasis. Individuals who are sexually contacted are diagnosed, tested, and treated if the infection is present. It is advisable to not have any sexual activity till the curation of disease to prevent the spread of infection.Â
Chronic Phase: It includes to manage and prevent trichomoniasis.Â
After the antibiotic treatment, patient must go for follow up test to conform the clearance of infection specifically during pregnancy. Take prevention which include safe sex and regular screening of STIs. Education of trichomoniasis is necessary to prevent it. Pregnant women must be closely monitored to premature birth and low birth weight need immediate treatment and follow up.Â
https://www.ncbi.nlm.nih.gov/books/NBK534826/

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
